Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hori, H.
Right arrow Articles by Kobayashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hori, H.
Right arrow Articles by Kobayashi, M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:2387-2394, 2002
© 2002 by the American Diabetes Association, Inc.

Association of SH2-Containing Inositol Phosphatase 2 With the Insulin Resistance of Diabetic db/db Mice

Hiroyuki Hori1, Toshiyasu Sasaoka2, Hajime Ishihara1, Tsutomu Wada1, Shihou Murakami1, Manabu Ishiki1, and Masashi Kobayashi1

1 First Department of Internal Medicine, Toyama Medical & Pharmaceutical University, Toyama, Japan
2 Department of Clinical Pharmacology, Toyama Medical & Pharmaceutical University, Toyama, Japan

SH-2-containing inositol 5'-phosphatase 2 (SHIP-2) is a physiologically important lipid phosphatase that functions to hydrolyze phosphatidylinositol (PI) 3-kinase product PI(3,4,5)P3 to PI(3,4)P2 in the negative regulation of insulin signaling. We investigated whether SHIP-2 is associated with the insulin resistance of diabetic db/db mice. The amount of SHIP-2 protein was elevated in quadriceps muscle and epididymal fat tissue, but not in the liver, of db/db mice relative to that in control db/+m mice. In accordance with the enhanced expression of SHIP-2, its localization at the membrane preparation was increased in the skeletal muscle and fat tissue of db/db mice. Insulin stimulation of PI 3-kinase activity was modestly decreased in skeletal muscle, fat tissue, and liver of db/db mice compared with that of db/+m mice. In addition to the modest decrease at the level of PI 3-kinase, the activity of Akt and protein kinase C (PKC)-{zeta}/{lambda}, which are downstream molecules of PI 3-kinase, was more severely reduced in the skeletal muscle and fat tissue, but not in liver of db/db mice. Treatment with the insulin-sensitizing agent rosiglitazone decreased the elevated expression of SHIP-2 in the skeletal muscle and fat tissue of db/db mice. Insulin-induced Akt activation and PKC-{zeta}/{lambda} phosphorylation were restored to the control level, although insulin-stimulated PI 3-kinase activation was minimally affected in the skeletal muscle and fat tissue of db/db mice. These results indicate that SHIP-2 is a novel molecule associated with insulin resistance in the skeletal muscle and fat tissue, and that insulin-induced activity of the downstream molecules of PI 3-kinase is decreased, at least in part, by the elevated expression of SHIP-2 in diabetic db/db mice.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Physiol.Home page
C. Frosig, M. P. Sajan, S. J. Maarbjerg, N. Brandt, C. Roepstorff, J. F. P. Wojtaszewski, B. Kiens, R. V. Farese, and E. A. Richter
Exercise improves phosphatidylinositol-3,4,5-trisphosphate responsiveness of atypical protein kinase C and interacts with insulin signalling to peptide elongation in human skeletal muscle
J. Physiol., August 1, 2007; 582(3): 1289 - 1301.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
R. DeKroon, J. B. Robinette, A. B. Hjelmeland, E. Wiggins, M. Blackwell, M. Mihovilovic, M. Fujii, J. York, J. Hart, C. Kontos, et al.
APOE4-VLDL Inhibits the HDL-Activated Phosphatidylinositol 3-Kinase/Akt Pathway via the Phosphoinositol Phosphatase SHIP2
Circ. Res., October 13, 2006; 99(8): 829 - 836.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ye, Y. Lin, S. Atar, M.-H. Huang, J. R. Perez-Polo, B. F. Uretsky, and Y. Birnbaum
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1158 - H1169.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. D. Hafstad, G. H. Solevag, D. L. Severson, T. S. Larsen, and E. Aasum
Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1763 - H1769.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Loffler, M. Bilban, M. Reimers, W. Waldhausl, and T. M. Stulnig
Blood Glucose-Lowering Nuclear Receptor Agonists Only Partially Normalize Hepatic Gene Expression in db/db Mice
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 797 - 804.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Benkirane, F. Amiri, Q. N. Diep, M. El Mabrouk, and E. L. Schiffrin
PPAR-{gamma} inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H390 - H397.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
R. V. Farese, M. P. Sajan, and M. L. Standaert
Insulin-Sensitive Protein Kinases (Atypical Protein Kinase C and Protein Kinase B/Akt): Actions and Defects in Obesity and Type II Diabetes
Experimental Biology and Medicine, October 1, 2005; 230(9): 593 - 605.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. Fukui, T. Wada, S. Kagawa, K. Nagira, M. Ikubo, H. Ishihara, M. Kobayashi, and T. Sasaoka
Impact of the Liver-Specific Expression of SHIP2 (SH2-Containing Inositol 5'-Phosphatase 2) on Insulin Signaling and Glucose Metabolism in Mice
Diabetes, July 1, 2005; 54(7): 1958 - 1967.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kagawa, T. Sasaoka, S. Yaguchi, H. Ishihara, H. Tsuneki, S. Murakami, K. Fukui, T. Wada, S. Kobayashi, I. Kimura, et al.
Impact of Src Homology 2-Containing Inositol 5'-Phosphatase 2 Gene Polymorphisms Detected in a Japanese Population on Insulin Signaling
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2911 - 2919.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. Carroll, A. N. Carley, J. R. B. Dyck, and D. L. Severson
Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E900 - E906.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. K. Prasad and S. J. Decker
SH2-containing 5'-Inositol Phosphatase, SHIP2, Regulates Cytoskeleton Organization and Ligand-dependent Down-regulation of the Epidermal Growth Factor Receptor
J. Biol. Chem., April 1, 2005; 280(13): 13129 - 13136.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. M. Zabolotny, F. G. Haj, Y.-B. Kim, H.-J. Kim, G. I. Shulman, J. K. Kim, B. G. Neel, and B. B. Kahn
Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action
J. Biol. Chem., June 4, 2004; 279(23): 24844 - 24851.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Sasaoka, T. Wada, K. Fukui, S. Murakami, H. Ishihara, R. Suzuki, K. Tobe, T. Kadowaki, and M. Kobayashi
SH2-containing Inositol Phosphatase 2 Predominantly Regulates Akt2, and Not Akt1, Phosphorylation at the Plasma Membrane in Response to Insulin in 3T3-L1 Adipocytes
J. Biol. Chem., April 9, 2004; 279(15): 14835 - 14843.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Trivedi, A. Marwaha, and M. Lokhandwala
Rosiglitazone Restores G-Protein Coupling, Recruitment, and Function of Renal Dopamine D1A Receptor in Obese Zucker Rats
Hypertension, February 1, 2004; 43(2): 376 - 382.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. E. McCurdy, R. T. Davidson, and G. D. Cartee
Brief calorie restriction increases Akt2 phosphorylation in insulin-stimulated rat skeletal muscle
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E693 - E700.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. Sasaoka, K. Kikuchi, T. Wada, A. Sato, H. Hori, S. Murakami, K. Fukui, H. Ishihara, R. Aota, I. Kimura, et al.
Dual Role of Src Homology Domain 2-Containing Inositol Phosphatase 2 in the Regulation of Platelet-Derived Growth Factor and Insulin-Like Growth Factor I Signaling in Rat Vascular Smooth Muscle Cells
Endocrinology, September 1, 2003; 144(9): 4204 - 4214.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.